BAYRY's subsidiary BlueRock reports 36-month data showing its Parkinson's therapy bemdaneprocel remains safe and effective in ...

Zimislecel is an allogeneic stem cell–derived islet-cell therapy. Data on the safety and efficacy of zimislecel in persons with type 1 diabetes are needed. We conducted a phase 1–2 study of zimislecel ...

Sexual size differences are widespread in biology, yet the "how" behind them often remains vague. We asked a concrete ...

September is National Sickle Cell Awareness Month in the USA, designated by Congress to help focus attention on the need for ...

Living with an autoimmune disease often means navigating a lifelong, complex condition. A recent study estimates that ...

New data from a gene therapy trial provide the first credible evidence that the progression of Huntington’s disease may be ...

“The promise of PredicTcell goes far beyond data,” said Mittul Mehta, CIO and Head of Tevogen.AI. “If our tools continue to deliver as they have so far, Tevogen stands to create T-cell therapies where ...